Cryder Capital Partners LLP: HCA HEALTHCARE INC (HCA): Quarterly 13F Position History
As of Q1 2026, Cryder Capital Partners LLP reported 454,444 shares of HCA HEALTHCARE INC (HCA), worth $215.1M and representing 14.0% of its 13F equity book. Quarter-over-quarter share count change: 75,701 (-14.3%) . The position first appeared in Q2 2016 and has been disclosed across 40 13F-HR filings in Pactolio's tracked window.
- 454,444Shares Held (Latest Filing)
- $215.1MReported Market Value (Latest Filing)
- 14.0%Portfolio Weight (% of 13F Equity Book)
- 75,701Quarter-over-Quarter Share Change
- -$32.4MQuarter-over-Quarter Value Change
- 1,121,719Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 40 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 454,444 | 75,701 | -14.3% | $215.1M | 14.0% | $473.2 |
| Q4 2025 | 530,145 | 74,614 | -12.3% | $247.5M | 14.6% | $466.9 |
| Q3 2025 | 604,759 | 0 | — | $257.7M | 14.2% | $426.2 |
| Q2 2025 | 604,759 | +34,994 | +6.1% | $231.7M | 13.0% | $383.1 |
| Q1 2025 | 569,765 | 0 | — | $196.9M | 14.7% | $345.6 |
| Q4 2024 | 569,765 | 32,324 | -5.4% | $171.0M | 12.4% | $300.1 |
| Q3 2024 | 602,089 | 0 | — | $244.7M | 14.1% | $406.4 |
| Q2 2024 | 602,089 | 274,515 | -31.3% | $193.4M | 12.1% | $321.3 |
| Q1 2024 | 876,604 | +35,547 | +4.2% | $292.4M | 12.7% | $333.5 |
| Q4 2023 | 841,057 | 77,055 | -8.4% | $227.7M | 11.3% | $270.7 |
| Q3 2023 | 918,112 | 2,871 | -0.3% | $225.8M | 10.9% | $246.0 |
| Q2 2023 | 920,983 | 2,983 | -0.3% | $279.5M | 13.6% | $303.5 |
| Q1 2023 | 923,966 | 8,563 | -0.9% | $243.6M | 13.0% | $263.7 |
| Q4 2022 | 932,529 | 186,253 | -16.6% | $223.8M | 13.8% | $240.0 |
| Q3 2022 | 1,118,782 | 1,360 | -0.1% | $205.6M | 12.8% | $183.8 |
| Q2 2022 | 1,120,142 | +83,278 | +8.0% | $188.3M | 10.3% | $168.1 |
| Q1 2022 | 1,036,864 | 84,855 | -7.6% | $259.9M | 12.8% | $250.6 |
| Q4 2021 | 1,121,719 | 0 | — | $288.2M | 13.0% | $256.9 |
| Q3 2021 | 1,121,719 | 0 | — | $272.3M | 13.6% | $242.7 |
| Q2 2021 | 1,121,719 | +146,308 | +15.0% | $231.9M | 12.1% | $206.7 |
| Q1 2021 | 975,411 | 0 | — | $160.4M | 12.8% | $164.5 |
| Q4 2020 | 975,411 | +23,321 | +2.4% | $160.4M | 12.8% | $164.5 |
| Q3 2020 | 952,090 | +144,607 | +17.9% | $118.7M | 11.0% | $124.7 |
| Q2 2020 | 807,483 | 0 | — | $78.4M | 8.5% | $97.1 |
| Q1 2020 | 807,483 | 89,270 | -10.0% | $72.6M | 10.6% | $89.8 |
| Q4 2019 | 896,753 | 0 | — | $132.5M | 15.0% | $147.8 |
| Q3 2019 | 896,753 | +81,226 | +10.0% | $108.0M | 13.9% | $120.4 |
| Q2 2019 | 815,527 | +124,953 | +18.1% | $110.2M | 16.3% | $135.2 |
| Q1 2019 | 690,574 | +5,392 | +0.8% | $90.0M | 13.8% | $130.4 |
| Q4 2018 | 685,182 | 84,642 | -11.0% | $85.3M | 15.5% | $124.5 |
| Q3 2018 | 769,824 | 65,832 | -7.9% | $107.1M | 16.5% | $139.1 |
| Q2 2018 | 835,656 | +308,270 | +58.5% | $85.7M | 14.0% | $102.6 |
| Q1 2018 | 527,386 | +19,980 | +3.9% | $51.2M | 14.7% | $97.0 |
| Q4 2017 | 507,406 | +138,780 | +37.6% | $44.6M | 14.4% | $87.8 |
| Q3 2017 | 368,626 | 0 | — | $29.3M | 12.0% | $79.6 |
| Q2 2017 | 368,626 | 0 | — | $37.5M | 13.8% | $101.8 |
| Q1 2017 | 368,626 | 13,020 | -3.4% | $32.8M | 13.3% | $89.0 |
| Q4 2016 | 381,646 | +67,115 | +21.3% | $28.2M | 12.6% | $74.0 |
| Q3 2016 | 314,531 | +76,630 | +32.2% | $23.8M | 13.9% | $75.6 |
| Q2 2016 | 237,901 | — | — | $18.3M | 14.7% | $77.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Cryder Capital Partners LLP first disclose a HCA position in 13F-HR filings?
Cryder Capital Partners LLP first reported HCA HEALTHCARE INC (HCA) on its 13F-HR filing for the period ending 2016-06-30 (Q2 2016). The position has appeared on 40 reported quarters within Pactolio's tracked window.
What was Cryder Capital Partners LLP's most recent quarter-over-quarter share-count change in HCA?
Between Q4 2025 and Q1 2026, Cryder Capital Partners LLP reduced its HCA position by 75,701 shares (-14.3%), leaving 454,444 shares at a market value of $215.1M.
Does the implied price-per-share represent Cryder Capital Partners LLP's cost basis in HCA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.